• Sharoda Dasgupta, Sarah Reagan-Steiner, Dana Goodenough, Kate Russell, Mary Tanner, Lillianne Lewis, Emily E Petersen, Ann M Powers, Krista Kniss, Dana Meaney-Delman, Titilope Oduyebo, Dan O'Leary, Sophia Chiu, Pamela Talley, Morgan Hennessey, Susan Hills, Amanda Cohn, Christopher Gregory, and Zika Virus Response Epidemiology and Laboratory Team.
• MMWR Morb. Mortal. Wkly. Rep. 2016 Apr 22; 65 (15): 395-9.

AbstractCDC recommends Zika virus testing for potentially exposed persons with signs or symptoms consistent with Zika virus disease, and recommends that health care providers offer testing to asymptomatic pregnant women within 12 weeks of exposure. During January 3-March 5, 2016, Zika virus testing was performed for 4,534 persons who traveled to or moved from areas with active Zika virus transmission; 3,335 (73.6%) were pregnant women. Among persons who received testing, 1,541 (34.0%) reported at least one Zika virus-associated sign or symptom (e.g., fever, rash, arthralgia, or conjunctivitis), 436 (9.6%) reported at least one other clinical sign or symptom only, and 2,557 (56.4%) reported no signs or symptoms. Among 1,541 persons with one or more Zika virus-associated symptoms who received testing, 182 (11.8%) had confirmed Zika virus infection. Among the 2,557 asymptomatic persons who received testing, 2,425 (94.8%) were pregnant women, seven (0.3%) of whom had confirmed Zika virus infection. Although risk for Zika virus infection might vary based on exposure-related factors (e.g., location and duration of travel), in the current setting in U.S. states, where there is no local transmission, most asymptomatic pregnant women who receive testing do not have Zika virus infection.

25 keywords...

hide…